Overregulating the chemistry industry jeopardizes innovation, jobs, and economic growth. Learn more.

Peer-Reviewed Research on Hexavalent Chromium

Eileen Conneely, M.P.H., J.D.
Three scientists looking at a petri dish.

The National Toxicology Program Report on Hexavalent Chromium

In 2008, the National Toxicology Program (NTP) reported that very high levels of Cr(VI) in drinking water caused small intestine tumors in laboratory rodents at extremely high concentrations of Cr(VI) (equivalent to 60,000 and 180,000 ppb).

However, because of the study design, NTP could not examine the mode of action (MOA), meaning how the chemical can cause cancer at the cellular level of an organism. It could not predict how the tumors occurred, how to extrapolate these high dose observations to lower, naturally occurring levels in drinking water, or whether these high dose findings are of biological relevance to humans. To put the high NTP doses into perspective, the Agency for Toxic Substances and Disease Registry (ATSDR) notes that typical U.S. drinking water supplies contain total chromium levels within a range of 0.2 – 35 ug/L with most supplies in the United States containing less than 5 ug/L [5 ppb] of chromium. Most U.S. drinking water supplies contain total chromium levels far below the current EPA drinking water standard of 100 ppb for total chromium.

Because the NTP study did not examine mode of action, which is important for scientists and regulators to understand when evaluating risk, the Hexavalent Chromium Panel (the Panel) of the American Chemistry Council (ACC) agreed to sponsor extensive studies that investigated not only which levels of Cr(VI) in drinking water can result in adverse effects like cancer, but also how hexavalent chromium can cause cancer in rodents. The studies also developed data describing the differences between rodents and humans in their ability to process and detoxify hexavalent chromium.

The Hexavalent Chromium Mode of Action Study

The Cr(VI) MOA study was designed to better understand how Cr(VI) causes cancer in rodents (e.g., mutagenic or non-mutagenic mode of action) and provide data and analyses to assist regulators in setting drinking water standards for Cr(VI). The studies were designed to mimic NTP conditions, and used mice and rats of the same strains and in similar experimental conditions (same animal feed/cages, same laboratory, same drinking water source) that were used in the 2008 NTP study.

The research led to the publication of over 30 peer-reviewed scientific papers that provide clear data that can help EPA and other regulators confidently set safe drinking water standards for hexavalent chromium. The published MOA research shows:

  • There was no observed toxicity in rodents exposed to concentrations of hexavalent chromium in drinking water at the current EPA maximum contaminant level (MCL) of 100 ppb for total chromium. In fact, at hexavalent chromium concentrations 10 times the current drinking water standard for total chromium, there was no observed toxicity in the rodents.
  • A mutagen is a toxicant that causes genetic mutation that changes the DNA and can be inherited by the next generation. Hexavalent chromium is not a mutagen (i.e., it has a threshold-based MOA) and drinking water containing less than or equal to 100 ppb total chromium would not be expected to cause cancer in humans. 
  • In the stomachs of both rodents and humans, Cr(VI) is naturally converted to Cr(III), the non-toxic form of chromium, and at relevant exposures, the conversion occurs more quickly and to a greater extent in humans than rodents. Thus, the science shows the current drinking water standard for total chromium is health protective. 

The research has undergone robust review, including review by an independent third-party Science Advisory Board, multiple rounds of peer review, and the research findings and all data have been made publicly available.